Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigens
- 1 January 1985
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 7 (2), 187-192
- https://doi.org/10.1016/0192-0561(85)90025-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- INOSIPLEX IN RECURRENT HERPES SIMPLEX INFECTIONSThe Lancet, 1982
- Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific epstein-barr virus antigen-induced lymphocyte responseInternational Journal of Cancer, 1982
- Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigenInternational Journal of Immunopharmacology, 1982
- Isoprinosine increases the antitumor action of interferonInternational Journal of Immunopharmacology, 1979
- The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitroInternational Journal of Immunopharmacology, 1979
- ISOPRINOSINE IN TREATMENT OF ACUTE VIRAL ENCEPHALITISThe Lancet, 1979
- Isoprinosine in subacute sclerosing panencephalitisNeurology, 1979
- IN VITRO STUDIES ON CELL‐MEDIATED IMMUNITY IN PATIENTS TREATED WITH INOSIPLEX FOR HERPES VIRUS INFECTION *Annals of the New York Academy of Sciences, 1977
- In vitro stimulation of human lymphocytes by Epstein-Barr virusCellular Immunology, 1972
- Delayed Cutaneous Hypersensitivity Reactions to Autologous Extracts of Burkitt-Lymphoma CellsNew England Journal of Medicine, 1970